Currently, I hold two positions:

Visiting Scholar, Dongguk University-Seoul (College of Pharmacy)

Associate Professor, Pharmaceutical Chemistry Department, Faculty of Pharmacy, Mansoura University, Egypt

01/2016 ~ Now

• Discovered 1-(3-(benzyloxy)pyridin-2-yl)-3-(2-(piperazin-1-yl)ethyl)urea: a new modulator for amyloid beta-induced mitochondrial dysfunction.
• Discovered 2-(4-chloro-2-aryloxyphenyl)-1,4-dihydroisoquinolin-3(2H)-ones as TSPO ligands blocking/enhancing Aβ-induced mPTP opening.
• Discovered new pyridyl/pyrazinyl thiourea derivatives as neuroprotective agents against amyloid-β-induced toxicity
• Identified Novel LCK/FMS inhibitors based on phenoxypyrimidine scaffold as potential treatment for inflammatory disorders
• Hit discovery of 4-amino-N-(4-(3-(trifluoromethyl)phenoxy)pyrimidin-5-yl)benzamide: A novel EGFR inhibitor from a designed small library
• Identified 2-(3-arylureido)pyridines and 2-(3-arylureido)pyrazines as potential modulators of Aβ-induced mitochondrial dysfunction in Alzheimer's disease
• Repositioned the antipsychotic trifluoperazine into new derivatives as anti-glioblastoma agents
• Discovered 1-(3-(Benzyloxy)pyrazin-2-yl)-3-(3,4-dichlorophenyl)urea, a new blocker of Aβ-induced mPTP opening for Alzheimer’s disease
• Discovered first-in-class thiazolidinedione derivatives as irreversible allosteric IKK-β modulators.